The medication was working
As a GLP-1 receptor agonist, it effectively mimics the natural incretin hormone, leading to a cascade of profound beneficial effects throughout the body: Stimulates Glucose-Dependent Insulin Release: It strategically helps the pancreas release insulin only when blood sugar levels are elevated, thereby efficiently lowering blood glucose
At Rivas, we work with patients every day to find dosing strategies that balance efficacy, tolerability, and budget, all backed by clinical data, not guesswork
Semaglutide is a GLP-1 receptor agonist that mimics the glucagon-like peptide-1 hormone, enhancing insulin secretion, reducing glucagon release, and slowing gastric emptying
This hormone is responsible for appetite suppression and a feeling of fullness or satiety